comparemela.com

Latest Breaking News On - Adicet bio inc - Page 9 : comparemela.com

HC Wainwright Trims Adicet Bio (NASDAQ:ACET) Target Price to $10 00

Adicet Bio (NASDAQ:ACET – Get Free Report) had its price objective lowered by research analysts at HC Wainwright from $26.00 to $10.00 in a research note issued to investors on Friday, Benzinga reports. The brokerage currently has a “buy” rating on the stock. HC Wainwright’s price objective points to a potential upside of 228.95% from […]

United statesAdicet bioOrbimed advisors llcAdicet bio incCapital managementAdicet bio company profileMetlife investment managementJpmorgan chase coAmerican international group incGet free reportDirector orbimed advisors llcInternational groupLife investment managementAdicet bio dailyNasdaq acetLower price target

Adicet Bio (NASDAQ:ACET) Price Target Lowered to $10 00 at HC Wainwright

Adicet Bio (NASDAQ:ACET – Get Free Report) had its price objective reduced by analysts at HC Wainwright from $26.00 to $10.00 in a note issued to investors on Friday, Benzinga reports. The brokerage currently has a “buy” rating on the stock. HC Wainwright’s price objective indicates a potential upside of 228.95% from the stock’s current […]

Adicet bioCapital partnersJacobs levy equity management incAdicet bio incCapital managementOrbimed advisors llcAcadian asset managementExchange traded conceptsGet free reportBio stock downDirector orbimed advisors llcTraded conceptsLevy equity managementAsset managementAdicet bio dailyNasdaq acet

Adicet Bio Reports Inducement Grant under Nasdaq Listing Rule 5635(c)(4)

Adicet Bio Reports Inducement Grant under Nasdaq Listing Rule 5635(c)(4)
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

Janhavi mohiteAnne bowdidgeStern investor relations incAdicet bio incInducement planNasdaq listing ruleAdicet bioInvestor relations

Adicet Bio Reports Inducement Grant under Nasdaq Listing Rule 5635(c)(4)

Adicet Bio, Inc. , a clinical stage biotechnology company discovering and developing allogeneic gamma delta T cell therapies for autoimmune diseases and cancer, today announced it granted an.

Adicet bio incAdicet bioInducement planNasdaq listing rule

Insider Buying: Adicet Bio, Inc (NASDAQ:ACET) Director Acquires 3,125,000 Shares of Stock

Adicet Bio, Inc. (NASDAQ:ACET – Get Free Report) Director Orbimed Advisors Llc bought 3,125,000 shares of the company’s stock in a transaction on Thursday, January 25th. The stock was purchased at an average cost of $2.40 per share, with a total value of $7,500,000.00. Following the completion of the transaction, the director now owns 7,526,359 […]

United statesAdicet bioOrbimed advisors llcMarquette asset managementAdicet bio incWells fargo companyTower research capitalAdicet bio company profileGet free reportDirector orbimed advisors llcTrail advisorsResearch capitalEmployees retirement systemAdicet bio dailyNasdaq acetInsider trading

vimarsana © 2020. All Rights Reserved.